Dr. Reddys Laboratories Ltd.
BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1245.50
-24.30 (-1.91%) Dr Reddy’s Laboratories informs about press release
Date: 28-01-2019Dr Reddy’s Laboratories has informed about press release titled ‘Dr. Reddy's Laboratories and its US subsidiary, Promius Pharma, announce FDA approval for TOSYMRA (sumatriptan nasal spray) 10 mg, in the US market.
The above information is a part of company’s filings submitted to BSE.